Bevacizumab and radiotherapy for the treatment of glioblastoma: brothers in arms or unholy alliance?
Niyazi, Maximilian, Harter, Patrick N.
, Hattingen, Elke , Rottler, Maya, von Baumgarten, Louisa, Proescholdt, Martin, Belka, Claus, Lauber, Kirsten and Mittelbronn, Michel
(2016)
Bevacizumab and radiotherapy for the treatment of glioblastoma: brothers in arms or unholy alliance?
Oncotarget 7 (3).
Date of publication of this fulltext: 17 Mar 2020 11:04
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Oncotarget | ||||
| Publisher: | IMPACT JOURNALS LLC | ||||
|---|---|---|---|---|---|
| Place of Publication: | ORCHARD PARK | ||||
| Volume: | 7 | ||||
| Number of Issue or Book Chapter: | 3 | ||||
| Date | 2016 | ||||
| Institutions | Medicine > Lehrstuhl für Neurochirurgie | ||||
| Identification Number |
| ||||
| Keywords | ENDOTHELIAL GROWTH-FACTOR; NEWLY-DIAGNOSED GLIOBLASTOMA; HIGH-GRADE GLIOMA; RECURRENT MALIGNANT GLIOMA; HYPOFRACTIONATED STEREOTACTIC RADIOTHERAPY; SINGLE-AGENT BEVACIZUMAB; RADIATION-THERAPY; ANTIANGIOGENIC THERAPY; TUMOR PROGRESSION; PLUS IRINOTECAN; glioma; radiotherapy; bevacizumab; angiogenesis; VEGF | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 41980 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric